Another 21 states reported they are “moderately” concerned they won’t have adequate supplies to administer COVID-19 vaccines.
The GAO report urged federal action to meet states’ needs for scarce supplies and to increase transparency in COVID-19 testing guidance. And HHS should make sure that the scientific reasons for any changes to testing guidelines are publicized in a timely manner, the report stated.
Shortages of medical supplies persist despite the efforts of HHS and the Federal Emergency Management Agency, the GAO said. One-third of states have reported a lack of testing supplies, such as rapid point-of-care tests, chemicals and instruments used in testing.
Certain types of personal protective equipment, including nitrile gloves, are also still in short supply, but most states reported they were able to fulfill most requests for PPE.
Find the full report here.
More articles on supply chain:
First mass shipment of Pfizer’s COVID-19 vaccine arrives in US
Connecticut company gets gets $590M US loan for disposable vaccine injector
Cost the biggest barrier to widespread coronavirus testing, survey finds
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.